Happy Pills? The Health Consequences of the Dramatic Increase in Antidepressant Use
The Economic Journal · 11.11.2026
DOI: 10.1093/ej/ueag142 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Economic Journal, online erschienen am 11.11.2026. Verfasst von Giuliano Masiero und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This paper examines the health consequences of the rapid increase in antidepressant consumption in Switzerland (2002–2014). Using a shift-share instrumental variable approach, we exploit regional variation in sales driven by product innovation (the shift) and the market power of pharmaceutical firms (the share). Our findings reveal that a one defined daily dose per 1,000 inhabitants increase in antidepressant sales raises hospital admissions for adverse drug reactions by 18% and for depression by 6%. Financial incentives for self-dispensing doctors and reduced access to psychotherapy emerge as key drivers, highlighting concerns about overtreatment and suboptimal prescribing practices.
Zitieren
APA
Masiero, G., Mazzonna, F., & Steinbach, S. (2026). Happy Pills? The Health Consequences of the Dramatic Increase in Antidepressant Use. The Economic Journal. https://doi.org/10.1093/ej/ueag142
Vancouver
Masiero G, Mazzonna F, Steinbach S. Happy Pills? The Health Consequences of the Dramatic Increase in Antidepressant Use. The Economic Journal. 2026. doi:10.1093/ej/ueag142
BibTeX
@article{Masiero2026,
author = {Masiero, Giuliano and Mazzonna, Fabrizio and Steinbach, Sandro},
title = {Happy Pills? The Health Consequences of the Dramatic Increase in Antidepressant Use},
journal = {The Economic Journal},
year = {2026},
doi = {10.1093/ej/ueag142}
}
EUVIMED